• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution.

作者信息

Moon Suk Bae, Han Sang Beom

机构信息

Department of Surgery, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.

Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.

出版信息

Patient Prefer Adherence. 2017 Jun 26;11:1069-1070. doi: 10.2147/PPA.S141868. eCollection 2017.

DOI:10.2147/PPA.S141868
PMID:29200831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5495131/
Abstract
摘要

相似文献

1
Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution.比马前列素/噻吗洛尔固定复方滴眼液的疗效与安全性。
Patient Prefer Adherence. 2017 Jun 26;11:1069-1070. doi: 10.2147/PPA.S141868. eCollection 2017.
2
Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.比马前列素/噻吗洛尔固定复方制剂在中国开角型青光眼或高眼压症患者中的安全性和有效性。
Chin Med J (Engl). 2014;127(5):905-10.
3
Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination.比马前列素联合噻吗洛尔固定复方制剂对比卡酰胺联合噻吗洛尔固定复方制剂治疗过的开角型青光眼患者的疗效
Curr Eye Res. 2016 Nov;41(11):1433-1437. doi: 10.3109/02713683.2015.1125507. Epub 2016 Apr 26.
4
Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.曲伏前列素 0.004%/噻吗洛尔 0.5% 固定联合制剂在从固定或不固定浓度的贝美前列素 0.03%/噻吗洛尔 0.5% 转换过来的患者中的应用。
Adv Ther. 2011 Aug;28(8):661-70. doi: 10.1007/s12325-011-0043-z. Epub 2011 Jul 15.
5
Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.0.03%比马前列素与0.5%噻吗洛尔固定复方制剂在广泛患者群体中的疗效、耐受性及安全性：多中心、开放标签观察性研究
Curr Med Res Opin. 2009 Apr;25(4):1037-43. doi: 10.1185/03007990902816947.
6
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.使用每日一次的比马前列素、噻吗洛尔凝胶剂或拉坦前列素进行24小时眼压控制：一项为期1个月的随机对照临床试验。
Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35. doi: 10.1016/j.survophthal.2003.12.017.
7
Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination.0.03%比马前列素与0.5%马来酸噻吗洛尔/2%多佐胺固定复方制剂的安全性和有效性
Eur J Ophthalmol. 2005 May-Jun;15(3):336-42. doi: 10.1177/112067210501500304.
8
A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension.一项为期三个月的多中心双盲研究，旨在比较0.004%曲伏前列素/0.5%噻吗洛尔滴眼液与0.004%曲伏前列素滴眼液和0.5%噻吗洛尔滴眼液同时给药对开角型青光眼或高眼压症患者的安全性和有效性。
J Glaucoma. 2005 Oct;14(5):392-9. doi: 10.1097/01.ijg.0000176935.08392.14.
9
[Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].[使用彩色多普勒成像评估比马前列素/噻吗洛尔固定复方制剂对高眼压症患者眼血流的影响。初步研究]
Arch Soc Esp Oftalmol. 2010 Apr;85(4):131-7.
10
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.比马前列素/噻吗洛尔固定组合与多佐胺/溴莫尼定/噻吗洛尔固定组合治疗原发性开角型青光眼或高眼压症患者的疗效和耐受性：一项多中心、前瞻性、交叉研究。
BMC Ophthalmol. 2014 Dec 19;14:161. doi: 10.1186/1471-2415-14-161.

引用本文的文献

1
Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients.预测早期乳腺癌患者口服抗雌激素治疗早期治疗不依从风险增加的因素。
Breast Cancer Res Treat. 2021 Jan;185(1):53-62. doi: 10.1007/s10549-020-05920-y. Epub 2020 Sep 12.

本文引用的文献

1
Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China.患者对固定复方比马前列素/噻吗洛尔滴眼液的满意度：一项针对中国青光眼患者的调查研究
Patient Prefer Adherence. 2017 Apr 28;11:845-852. doi: 10.2147/PPA.S131853. eCollection 2017.
2
Population-based glaucoma prevalence studies in Asians.亚洲人群的青光眼患病率研究。
Surv Ophthalmol. 2014 Jul-Aug;59(4):434-47. doi: 10.1016/j.survophthal.2013.09.003. Epub 2014 May 13.
3
Ocular surface disease and quality of life in patients with glaucoma.青光眼患者的眼表面疾病和生活质量。
Am J Ophthalmol. 2012 Jan;153(1):1-9.e2. doi: 10.1016/j.ajo.2011.05.033. Epub 2011 Aug 26.
4
Reduced corneal sensitivity in patients with primary Sjögren's syndrome.原发性干燥综合征患者角膜敏感性降低。
Acta Ophthalmol. 2010 Nov;88(7):e277-8. doi: 10.1111/j.1755-3768.2009.01693.x.